TY - JOUR
T1 - Nuclear versus cytoplasmic localization of filamin a in prostate cancer
T2 - Immunohistochemical correlation with metastases
AU - Bedolla, Roble G.
AU - Wang, Yu
AU - Asuncion, Alfredo
AU - Chamie, Karim
AU - Siddiqui, Salma
AU - Mudryj, Maria M.
AU - Prihoda, Thomas J.
AU - Siddiqui, Javed
AU - Chinnaiyan, Arul M.
AU - Mehra, Rohit
AU - De Vere White, Ralph W.
AU - Ghosh, Paramita M.
PY - 2009/2/1
Y1 - 2009/2/1
N2 - Purpose: We previously showed that nuclear localization of the actin-binding protein, filamin A (Fln A), corresponded to hormone-dependence in prostate cancer. Intact Fln A (280 k Da, cytoplasmic) cleaved to a 90 k Da fragment which translocated to the nucleus in hormone-naïve cells, whereas in hormone-refractory cells, Fln A was phosphorylated, preventing its cleavage and nuclear translocation. We have examined whether Fln A localization determines a propensity to metastasis in advanced androgen-independent prostate cancer. Experimental Design: We examined, by immunohistochemistry, Fln A localization in paraffin-embedded human prostate tissue representing different stages of progression. Results were correlated with in vitro studies in a cell model of prostate cancer. Results: Nuclear Fln A was significantly higher in benign prostate (0.6612 ± 0.5888), prostatic intraepithelial neoplasia (PIN; 0.6024 ± 0.4620), and clinically localized cancers (0.69134 ± 0.5686) compared with metastatic prostate cancers (0.3719 ± 0.4992, P = 0.0007). Cytoplasmic Fln A increased from benign prostate (0.0833 ± 0.2677), PIN (0.1409 ± 0.2293), localized cancers (0.3008 ± 0.3762, P = 0.0150), to metastases (0.7632 ± 0.4414, P < 0.00001). Logistic regression of metastatic versus nonmetastatic tissue yielded the area under the receiver operating curve as 0.67 for nuclear-Fln A, 0.79 for cytoplasmic-Fln A, and 0.82 for both, indicating that metastasis correlates with cytoplasmic to nuclear translocation. In vitro studies showed that cytoplasmic localization of Fln A induced cell invasion whereas nuclear translocation of the protein inhibited it. Fln dephosphorylation with the protein kinase A inhibitor H-89 facilitated Fln A nuclear translocation, resulting in decreased invasiveness and AR transcriptional activity, and induced sensitivity to androgen withdrawal in hormone-refractory cells. Conclusions: The data presented in this study indicate that in prostate cancer, metastasis correlates with cytoplasmic localization of Fln A and may be prevented by cleavage and subsequent nuclear translocation of this protein.
AB - Purpose: We previously showed that nuclear localization of the actin-binding protein, filamin A (Fln A), corresponded to hormone-dependence in prostate cancer. Intact Fln A (280 k Da, cytoplasmic) cleaved to a 90 k Da fragment which translocated to the nucleus in hormone-naïve cells, whereas in hormone-refractory cells, Fln A was phosphorylated, preventing its cleavage and nuclear translocation. We have examined whether Fln A localization determines a propensity to metastasis in advanced androgen-independent prostate cancer. Experimental Design: We examined, by immunohistochemistry, Fln A localization in paraffin-embedded human prostate tissue representing different stages of progression. Results were correlated with in vitro studies in a cell model of prostate cancer. Results: Nuclear Fln A was significantly higher in benign prostate (0.6612 ± 0.5888), prostatic intraepithelial neoplasia (PIN; 0.6024 ± 0.4620), and clinically localized cancers (0.69134 ± 0.5686) compared with metastatic prostate cancers (0.3719 ± 0.4992, P = 0.0007). Cytoplasmic Fln A increased from benign prostate (0.0833 ± 0.2677), PIN (0.1409 ± 0.2293), localized cancers (0.3008 ± 0.3762, P = 0.0150), to metastases (0.7632 ± 0.4414, P < 0.00001). Logistic regression of metastatic versus nonmetastatic tissue yielded the area under the receiver operating curve as 0.67 for nuclear-Fln A, 0.79 for cytoplasmic-Fln A, and 0.82 for both, indicating that metastasis correlates with cytoplasmic to nuclear translocation. In vitro studies showed that cytoplasmic localization of Fln A induced cell invasion whereas nuclear translocation of the protein inhibited it. Fln dephosphorylation with the protein kinase A inhibitor H-89 facilitated Fln A nuclear translocation, resulting in decreased invasiveness and AR transcriptional activity, and induced sensitivity to androgen withdrawal in hormone-refractory cells. Conclusions: The data presented in this study indicate that in prostate cancer, metastasis correlates with cytoplasmic localization of Fln A and may be prevented by cleavage and subsequent nuclear translocation of this protein.
UR - http://www.scopus.com/inward/record.url?scp=61349085591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=61349085591&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-08-1402
DO - 10.1158/1078-0432.CCR-08-1402
M3 - Article
C2 - 19188148
AN - SCOPUS:61349085591
VL - 15
SP - 788
EP - 796
JO - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 3
ER -